Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32389443.
- Also identified by DOI 10.1016/j.eururo.2020.04.016 and PMC identifier 8327360.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Guidelines now recommend multiparametric magnetic resonance imaging before prostate biopsy in the work-up for patients with elevated prostate specific-antigen. However, use of magnetic resonance imaging for early detection of prostate cancer is not justified by the clinical trial evidence.
Medical subject headings
- Early Detection of Cancer
- Magnetic Resonance Imaging
- Prostatic Neoplasms